Related Experiment Video
Updated: Mar 30, 2026

10:11
Modeling The Lifecycle Of Ebola Virus Under Biosafety Level 2 Conditions With Virus-like Particles Containing Tetracistronic Minigenomes
Published on: September 27, 2014
37.2K
Getting the most from the Ebola vaccine success
Daniele Focosi1, Fabrizio Maggi2, Mauro Pistello3
1North-Western Tuscany Blood Bank, Pisa University Hospital, Italy.
Vaccine
|November 12, 2015
Abstract
No abstract available in PubMed .
Related Concept Videos
Cross-reactivity
33.8K
Overview
33.8K
Vaccinations
53.8K
Overview
53.8K
Vaccine Production
57
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
57
Vaccines
42
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
42

